MCJR Joint Replacement Clinical Outcomes Database
ConditionJoint Replacement
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMidwest Center for Joint Replacement
About this trial
The purpose of this research study is to develop a database of information regarding the diagnosis, treatment, and outcome of participants who have had a joint replacement. The more information gathered, the better the investigators will be able to treat future patients who need a joint replacement. For example the investigators learn what works well to help design implants and treatment protocols for the future. The investigators publish manuscripts and present research findings around the world to help other investigators and clinicians learn what is discovered. Furthermore, implant manufacturers may be able to use this information in the database to evaluate the success rates of specific joint replacement products.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Joint Replacement Patients: Clinical diagnosis of degenerative joint disease requiring treatment with a joint replacement of the hip and knee
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Hip and Knee Joint Replacement
DeviceHip and Knee Joint Replacement
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Oxford Knee Score
OKS - PROM
Time frame
Change in OKS from Baseline at 1 year, assessed up to 30 years2
HOOS
Hip Outcome scores
Time frame
Change in HOOS from Baseline at 1 year, assessed up to 30 years3
KOOS
Knee Outcome scores
Time frame
Change in HOOS from Baseline at 1 year, assessed up to 30 yearsSecondary outcomes
1
radiographic findings
x-ray reports of joint replacements
Time frame
Change in radiographic findings from Baseline at 1 year, assessed up to 30 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Midwest Center for Joint Replacement
Lead sponsor
University of Oxford
Collaborator
Source ClinicalTrials.gov